Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum ; volume:146 ; number:3 ; day:19 ; month:7 ; year:2023 ; pages:433-450 ; date:9.2023
Acta neuropathologica ; 146, Heft 3 (19.7.2023), 433-450, 9.2023
- Creator
-
Gittings, Lauren M.
Alsop, Eric B.
Antone, Jerry
Singer, Mo
Whitsett, Timothy G.
Sattler, Rita
Keuren-Jensen, Kendall Van
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-023-02599-5
- URN
-
urn:nbn:de:101:1-2023110209115154689301
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gittings, Lauren M.
- Alsop, Eric B.
- Antone, Jerry
- Singer, Mo
- Whitsett, Timothy G.
- Sattler, Rita
- Keuren-Jensen, Kendall Van
- SpringerLink (Online service)
Other Objects (12)
The era of cryptic exons: implications for ALS-FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes
The era of cryptic exons: implications for ALS-FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes
The era of cryptic exons: implications for ALS-FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA